Compare S H Kelkar & Co. with Similar Stocks
Stock DNA
Specialty Chemicals
INR 2,090 Cr (Small Cap)
22.00
38
0.68%
0.60
7.03%
1.52
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Aug-01-2025
Risk Adjusted Returns v/s 
Returns Beta
News

S H Kelkar & Company Ltd Technical Momentum Shifts Amid Bearish Signals
S H Kelkar & Company Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite some mixed signals across weekly and monthly timeframes, the overall technical outlook suggests caution for investors amid a weakening price momentum and deteriorating moving averages.
Read full news article
S H Kelkar & Company Ltd is Rated Sell
S H Kelkar & Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 6 January 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 January 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.
Read full news article
S H Kelkar & Company Ltd Technical Momentum Shifts Amid Mixed Market Signals
S H Kelkar & Company Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day change of 0.16%, the stock’s weekly and monthly signals reveal a mixed picture, underscoring the need for investors to carefully analyse momentum and trend shifts within the Specialty Chemicals sector.
Read full news article Announcements 
S H Kelkar and Company Limited - Updates
09-Dec-2019 | Source : NSES H Kelkar and Company Limited has informed the Exchange regarding 'Postal Ballot Results under Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 ( Listing Regulations )'.
S H Kelkar and Company Limited - Updates
05-Dec-2019 | Source : NSES H Kelkar and Company Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
S H Kelkar and Company Limited - Analysts/Institutional Investor Meet/Con. Call Updates
26-Nov-2019 | Source : NSES H Kelkar and Company Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates Intimation of Investor meeting/call pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Corporate Actions 
No Upcoming Board Meetings
S H Kelkar & Company Ltd has declared 10% dividend, ex-date: 01 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
5.662
Held by 5 Schemes (5.56%)
Held by 54 FIIs (6.79%)
Ramesh Vinayak Vaze Family Trust (ramesh Vaze, Prabha Vaze & Kedar Vaze-in The Capacity Of Trustee) (19.51%)
Firmenich Aromatics Production (india) Pvt Ltd (9.8%)
18.03%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -4.61% vs 2.34% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -64.10% vs -75.06% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 12.02% vs 12.42% in Sep 2024
Growth in half year ended Sep 2025 is 174.25% vs -182.77% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 13.36% vs 13.06% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -132.99% vs 50.78% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 15.35% vs 9.15% in Mar 2024
YoY Growth in year ended Mar 2025 is -40.17% vs 100.13% in Mar 2024






